Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

The distribution of oxytocin and the oxytocin receptor in rat brain: relation to regions active in migraine

Abstract

Background

Recent work, both clinical and experimental, suggests that the hypothalamic hormone oxytocin (OT) and its receptor (OTR) may be involved in migraine pathophysiology.

In order to better understand possible central actions of OT in migraine/headache pathogenesis, we mapped the distribution of OT and OTR in nerve cells and fibers in rat brain with a focus on areas related to migraine attacks and/or shown previously to contain calcitonin gene related peptide (CGRP), another neuropeptide involved in migraine.

Methods

Distribution of OT and OTR in the adult, rat brain was qualitatively examined with immunohistochemistry using a series of well characterized specific antibodies.

Results

As expected, OT was extensively localized in the cell somas of two hypothalamic nuclei, the supraoptic (SO or SON) and paraventricular nuclei (Pa or PVN). OT also was found in many other regions of the brain where it was localized mainly in nerve fibers. In contrast, OTR staining in the brain was mainly observed in cell somas with very little expression in fibers. The most distinct OTR expression was found in the hippocampus, the pons and the substantia nigra. In some regions of the brain (e.g. the amygdala and the hypothalamus), both OT and OTR were expressed (match). Mismatch between the peptide and its receptor was primarily observed in the cerebral and cerebellar cortex (OT expression) and hippocampus (OTR expression).

Conclusions

We compared OT/OTR distribution in the CNS with that of CGRP and identified regions related to migraine. In particular, regions suggested as “migraine generators”, showed correspondence among the three mappings. These findings suggest central OT pathways may contribute to the role of the hypothalamus in migraine attacks.

Introduction

Oxytocin (OT) is a nine amino acid peptide (nonapeptide) structurally similar to peptide arginine vasopressin, an antidiuretic hormone, which differs from OT in two of the nine amino acid residues. These two hormones exhibit in their structure pronounced evolutionary stability [1]. Numerous studies have been performed on the expression of OT in the brain using e.g. radio-immunoassays, autoradiography, electrophysiology, OT receptor-lacZ reporter mouse, OT binding sites studies and immunohistochemistry. These have shown that OT, together with vasopressin, are synthesized in magnocellular neurosecretory cells in the supraoptic (SO or SON) and paraventricular nuclei (Pa or PVN) in the hypothalamus [2,3,4,5,6,7,8]. In addition, some OT is released from centrally projecting parvocellular neurons of the Pa. These contain however much less peptide levels than do the magnocellular neurons [9]. Groups of oxytocinergic cells outside of SO/Pa are called “accessory neurons”. The magnocellular neurons of SO and Pa project to the posterior pituitary gland where they release OT into the bloodstream thus controlling endocrine events associated with reproduction in both males and females [10]. In addition, OT is released from the cell bodies and dendrites of these neurons [11]. It is still valid that OT neurons are confined to the hypothalamus, even though there seems to be a vast functional diversity. In contrast, the expression of the oxytocin receptor (OTR) is abundant throughout the brain [10], however, the functional role is still unclear.

A steadily increasing number of publications on the molecular, physiological, pharmacological, and behavioral significance of OT, the underlying neuroanatomical and neurochemical basis have been studied to a much lesser extent. This is especially true for OT projections within brain [10].

OT plays a central role in initiating the onset of maternal behavior. In addition to its involvement in uterine contraction, lactation and psychosocial processes, OT has also been implicated in many central processes, including learning and memory, anxiety, addiction, feeding behavior, sexual control and processing of social information [12]. Compared to the vasopressin system, there are fewer sex differences in OT synthesis and expression in the brain and, if any of such, sex differences are specific to brain regions and species [13]. In males, and females, OT neurons are continuously active. In males, OT is involved in reproductive functions such as ejaculation, in cardiovascular homeostasis and other peripheral activities [14]. Significantly, OT is implicated as an endogenous modulator of pain originating from the trigeminal nociceptive system [15].

The ability to artificially synthesize and intranasal administer OT has catalyzed fast-growing line of research on clinical and healthy populations. Acute, single-dose trials are not representative of long-term treatment. Because certain functional impairments have lifelong impacts on quality of life (e.g., schizophrenia, stress disorders), it is improbable that a single administration will constitute an effective treatment plan [16, 17]. Daily OT administration offers greater ecological validity in assessing the neuropeptide’s efficacy as a treatment [16]. In addition, a systematic review of the available literature showed that OT had a reliable effect as defined by increasing “pain” tolerance in 29 of 33 animal studies [18]. The results suggested that OT acts as an analgesic for acute “pain” in animals. Research with humans offers consistent evidence to suggest that OT decreases “pain” sensitivity [18].

Migraine is currently rank sixth in worldwide prevalence, 15% of the population suffers migraine, 3 times more women than men, and is posing a heavy burden on individuals and society [19]. While much remains to be unraveled regarding the neurobiology of migraine, emerging evidence links the hypothalamus with the “migraine generator” in the dorsal rostral pons as well as with the spinal trigeminal nuclei and sensory trigeminovascular system (Fig. 1a), a key pathway in transmission of headache pain [21]. An important focus of migraine research has been identifying possible neuromodulators, primarily neuropeptides, involved in migraine pathophysiology [22].

Fig. 1
figure1

Sagittal cryo-sections stained with Hematoxylin and Eosin. The 6th edition of The Rat Brain in Stereotaxic Coordinates by Paxinos and Watson [20] was used to identify the different areas. a Migraine related regions. b CGRP distribution. c Oxytocin and oxytocin receptor expression. Yellow color denotes oxytocin and pink oxytocin receptor immunoreactivity

Circumstantial evidence has pointed us to propose that OT might be involved in migraine, for example the increase of circulating OT during pregnancy correlates with decrease the frequency of headache, and breastfeeding results in higher levels of circulating OT and less postpartum migraine reoccurrence [23]. Clearly, men also suffer from migraine, but so far no differences in OT levels between mothers and fathers have been demonstrated (reviewed [24]).

Therefore, the aim of the present study was to comprehensively map the distribution of OT and OTR in the male rat brain in order to provide an qualitative overview of their localization in fibres and cells to add to the discussion of migraine/headache pathogenesis in general and to compare with their localization with that of calcitonin gene-related peptide (CGRP) and CGRP receptors in the brain [25].

Materials and methods

The study followed the guidelines of the European Communities Council (86/609/ECC) and was approved by the Regional Ethical Committee on Animal Research, Malmö/Lund, Sweden (M17–15).

Ten Wistar male rats were euthanized by CO2 inhalation followed by decapitation. The brains were carefully dissected, cut sagittal in the midline and placed in 4% paraformaldehyde (PF) in phosphate buffer for 4 h, followed by incubation overnight in Sörensen’s phosphate buffer (pH 7.2) containing 10% and 25% sucrose in turn. This method of PF fixation allows for a proper fixation up to 2–3 mm from the surface of the brain and inwards [26]. Since we examine a volume of 1 mm lateral to the midline (+ 0.5 − + 1.5 mm), a proper fixation of the tissue used for the immunohistochemical investigation is achieved. The tissue was embedded in Yazulla embedding medium (30% egg albumin, 3% gelatin) and cryo-sectioned at 12 μm. The sections were stored at − 20 °C until use.

The 6th edition of The Rat Brain in Stereotaxic Coordinates by Paxinos and Watson [20] and HE staining of sagittal sections spanning over 0.5 mm to 1.5 mm lateral to the midline were used to identify the different areas subjected to the detailed study of OT and OTR distribution. The methods used in the present study are the same as published earlier [25]. However, it is not the same brains as the ones published.

Hematoxylin-eosin (HE)

Sagittal cryo-sections of the whole brain, including cerebellum, brain stem and C1 spinal cord were stained using Hematoxylin and Eosin (Htx 4 min, Eosin 1 min). The staining was done in order to examine the morphology and condition of the tissue, and to identify the distance of the section of the brain from the midline. HE staining of sagittal sections spanning over 0.5 mm to 1.5 mm lateral to the midline (Figs. 1a-c) were used to identify the different areas subjected to the detailed study of the OT and OTR distribution.

Immunohistochemistry

Sagittal sections of the brain (lateral 0.5–1.5 mm) were washed in phosphate buffered saline (PBS) containing 0.25% Triton-X (PBS-T) for 15 min followed by application of the primary antibody (Table 1) with incubation overnight at + 4 °C in moisturized incubation chambers. The following day, the sections were washed twice in PBS-T for 15 min prior to incubation with secondary antibodies (Table 1) for 1 h in room temperature. Finally, the sections were washed 2 × 15 minutes and mounted with Vectashield mounting medium containing 4′,6-diamidino-2-phenylindole (DAPI) (Vector Laboratories, Burlingame CA, USA).

Table 1 Details of the primary and secondary antibodies

Three different OT antibodies and 4 OTR antibodies were tested. Anti-rabbit Oxytocin AB911 from Millipore and anti-guinea pig Oxytocin PA1–18416 from ThermoFisher displayed consistent and comparable results, and were therefore used in the mapping. As regards to OTR antibodies, anti-goat oxytocin receptor ab87312 from Abcam and anti-rabbit oxytocin receptor AVR-013 from Alomone also showed consistent and comparable results, and were therefore used in the present study. Three to six stainings per antibody were performed. Several secondary antibodies were tested and the best results were achieved using FITC anti-rabbit, Alexa 488 anti-guinea pig and Cy2 anti-goat secondary antibodies. Thus, all positive images in the Results are indicated by green immunofluorescence. For further details of the antibodies used, see Table 1. Omission of primary antibodies served as negative controls.

To compare the OT and OTR distribution with that of CGRP and CGRP receptor, immunohistochemistry was performed on some CNS areas (for information on antibodies, see Table 1). We have recently published the distribution of CGRP and CGRP receptor components in the rat brain [25].

The sections were examined in a light and epifluorescence microscope (Nikon 80i, Tokyo, Japan) equipped with a motor table, enabling us to get images of a whole section, and with a Nikon DS-2MV camera. Finally, images were processed using Adobe Photoshop CS3 (v0.0 Adobe Systems, Mountain View, CA).

Results

The results of our OT/OTR mapping study is summarized in Fig. 1c. We have compared this distribution with brain areas identified in imaging studies of humans experiencing a migraine attack [27] (Fig. 1a). In addition, we have correlated our findings with that from our recent study on CNS localization of CGRP, another neuropeptide associated with migraine pathophysiology [25] (Fig. 1b).

OT distribution

As expected, OT was expressed in numerous neuronal soma within the supraoptic (SO) and paraventricular (Pa) nuclei of the hypothalamus. These nuclei are considered the primary origin of OT projections throughout the brain as well as the OT projections to the posterior pituitary where this neurohormone is released into the circulation [28]. Consistent with this view, OT immunoreactivity observed in other parts of the brain was found mainly in fiber structures but not cell somas. OT fibers exhibited a widespread distribution in the brain. Pearl-like staining of some fibres was also observed within the SO (Fig. 2) and Pa (Fig. 3).

Fig. 2
figure2

Oxytocin immunohistochemistry of the supraoptic nucleus and optic chiasm. a. A and B. The image shows immunoreactive magnocellular neurons of the supraoptic nucleus (SO). The optic chiasm (och), close to the SO, shows no immunoreactivity. Immunoreactive fibers in the medial preoptic area (MPA) are seen. Insert in B: Higher magnification of stained magnocellular neurons and occasional thin fibers

Fig. 3
figure3

Oxytocin immunohistochemistry of the paraventricular hypothalamic nucleus and the arcuate nucleus. a. The Arcuate nucleus (Arc), that project to the SO and paraventricular hypothalamic nucleus (Pa), show intense oxytocin expression. b. Pa, a nucleus of neurosecretory cells in the hypothalamus, exhibits intense oxytocin staining. As in the SO, pearl-like fibers expressing oxytocin also were found

Overall there were few cell bodies in the CNS that contained OT apart from those in the hypothalamic SO and Pa nuclei. Some OT immunoreactive cells were found in the lateral reticular nucleus (LRt) and Sp5. In addition, OT immunoreactive neuron are also found in the TNC (Warfvinge, unpublished.

The arcuate nucleus (Arc), which projects to the SO and Pa, expressed intense OT staining in nerve fibres (Fig. 3). These fibers join to distribute to the tract to the pituitary gland [10]. The Arc is considered a key component of neuroendocrine circuitry e.g. OT neurons in the Pa receive neural projections from the Arc [29].

In cerebral cortex, OT immunoreactive neuronal processes were found spanning through layers III to VI. Both vertical and horizontal slender processes were observed, forming network structures. OT immunoreactivity was not observed in the cell soma (Figs. 4a-c). Earlier we published a detailed study of CGRP and its receptor components RAMP1/CLR [25]. Figure 4d shows the CGRP receptor activity-modifying protein 1 (RAMP1) in long slender processes that is similar to the OT distribution in cerebral cortex.

Fig. 4
figure4

Oxytocin immunohistochemistry of the cerebral cortex. a. Thin fibers of layers III-VI of the motor cortex displayed oxytocin immunoreactivity. b and c. These fibers spanned through the layers in a delicate and well-defined pattern. Layer III (b) and layers V-VI (c) are shown in a higher magnification. d. As a comparison, the calcitonin gene-related peptide (CGRP) receptor component (receptor activity-modifying protein 1) RAMP1 is shown in the right panel. These results have been published earlier [25]. We showed that RAMP1 positive fibers spanned through the cortical layers, but here layer II positivity was found. In addition to the transversal positive fibers, RAMP1 positive horizontal fibers were revealed

Cerebellar cortex consists of three distinct layers: the molecular, Purkinje cell (PC) and granule cell layers. The only excitatory neurons present are granule cells. The function of cerebellar circuits, which are believed to be important for motor learning, is entirely dependent on processes carried out by the granular layer. OT immunohistochemistry was revealed in slender processes within the granular cell layer. No immunoreactivity was found in the molecular layer, PC soma or in the most central areas of the cerebellar white matter (Fig. 5a). The staining pattern of OT in the granular layer is similar to that shown previously for the RAMP1 component of the CGRP receptors [25]. However, OT was not present in the white matter, as it was for RAMP1 or in any of the cerebellar neuronal cell bodies (Fig. 5c).

Fig. 5
figure5

Oxytocin immunohistochemistry in the cerebellum and the Mesencephalic trigeminal nucleus. a. Oxytocin immunoreactivity was found in fibers in the cerebellar white matter and to some extend in the granular cell layer. No oxytocin positivity was observed in the Purkinje cell layer (PC) or the molecular layer. Insert: a low magnification image of cerebellar lobes. X indicates where the large magnification image is selected. b. In the Mesencephalic trigeminal nucleus (Me5), intense oxytocin immunoreactivity was found. In addition, surrounding the Me5 positive slender fibers were demonstrated. Insert: Higher magnification of Me5. c. The lower row shows in comparison RAMP1 immunoreactivity [25]. The staining of the white matter agrees with the one seen in the oxytocin staining. However, RAMP1 is also found in PC, which is not the case with oxytocin. d. RAMP1 staining showed distinct neuronal cytoplasmatic staining and, in addition, thick fiber immunoreactivity

The mesencephalic nucleus (Me5) is involved with proprioception of the face, the feeling of position of the muscles. In this nucleus, OT immunoreactive fibre structures were detected (Fig. 5b). This finding was in contrast with the staining of RAMP1, which was observed in the cell bodies of Me5 (Fig. 5d). The medial cerebellar nucleus (Med) contains large neurons intermixed with small neurons. The larger cells project to a variety of targets outside the cerebellum. The smaller cells project exclusively to the inferior olive (IO), the source of climbing fibers. OT immunoreactivity in the Med exhibited intense fiber staining, often so tight and close to the cell nuclei that it appeared like cell body staining (Fig. 6).

Fig. 6
figure6

Oxytocin immunohistochemistry of the medial cerebellar nucleus (Med). Med contained large neurons intermixed with small neurons. Med exhibited intense oxytocin fiber staining, often so close to the cell nuclei that it appears like cell body staining

The anterior commissure (ac) is a white matter tract connecting the two temporal cerebral lobes across the midline and placed in front of the fornix (f). The bed nucleus is a center of integration for limbic information and monitoring. The zona incerta (ZI) is a horizontally elongated region of gray matter below the thalamus. OT immunohistochemistry revealed fiber positivity in ac, bed nucleus and ZI. No immunoreactivity was found in the fornix (Fig. 7).

Fig. 7
figure7

Oxytocin immunohistochemistry of the anterior commissure, bed nucleus and zona incerta. a. The white matter tract anterior commissure (ac) showed distinct fiber oxytocin immunoreactivity in fibers (Insert: higher magnification of ac). In addition, fibers in the bed nucleus also expressed oxytocin. b The zona incerta displayed intense oxytocin immunoreactivity in thin fibers

In the reticular formation, a few cells - the lateral reticular nucleus (LRt) – were found to express OT. These few cells are the only cells in addition to SO, Pa and Sp5 (and TNC, see above) that were OT immunoreactive in the brain. LRt receives fibers from the spinal cord and motor cortex and projects to the cerebellum, controlling consciousness (Fig. 8).

Fig. 8
figure8

Oxytocin immunohistochemistry in the lateral reticular nucleus. In the reticular formation, a few bodies of the lateral reticular nucleus (LRt) were found to express oxytocin

The term pyramidal tract (py) refers to motor neurons that originate in the motor cortex and terminate in the spinal cord or brainstem. We found OT expression in the fibres of the pyramidal tract. Adjacent to the pyramidal tract, there is the trapezoid body (tz) of the superior olivary complex, a collection of brainstem nuclei that functions in hearing. OT immunohistochemistry revealed staining of fibers in the trapezoid body (Fig. 9).

Fig. 9
figure9

Oxytocin immunohistochemistry of the pyramidal tract and the trapetzoid body. a and b. Oxytocin immunoreactive thin fibers were observed in the pyramidal tract (py) and the trapetzoid body (tz). c. In comparison, we have previously found RAMP1 immunohistochemistry displayed a pattern with both positive thick and thin fibers [25] (left image)

In the spinal trigeminal nucleus (Sp5), we found granular OT expression in some cell soma, but not in the fibers (Fig. 10). Sp5 receives trigeminal pain signals originating in the meninges. We have found OT expression in the soma of the neurons in another central trigeminal target, the trigeminal nucleus caudalis (TNC) (Warfvinge, unpublished). Here the staining exhibited a granular pattern in the cytoplasm. No OT immunoreactivity was observed in nerve fibres. No OTR immunoreactivity was detected in the TNC.

Fig. 10
figure10

Oxytocin immunohistochemistry of the Spinal trigeminal nucleus. To the right, oxytocin immunohistochemistry is shown. A few cell bodies (arrows) express oxytocin in the Sp5. No immunoreactivity was found in fibers (asterisk). The arrowhead points at a stained capillary. On the left, CGRP expression in this region [25] is shown for comparison. The square in the left panel indicates the approximate location of the area presented in the right panel

The islands of Calleja (ICj) are a group of neuronal granule cells that are located within the olfactory tubercle in rodents. This region is part of the limbic system, where it aids in the reinforcing effects of reward-like activities. We found thin, slender OT immunoreactive fibers in this region (Fig. 11).

Fig. 11
figure11

Oxytocin immunohistochemistry of the Islands of Calleja and the Pons. a. Thin slender processes in the Islands of Calleja (ICj) plus fibers structures in the surrounding area were oxytocin immunoreactive. b. In the pontine nucleus (Pn), the neurons were surrounded by thin oxytocin positive fibers (insert)

The pons (Pn) is a portion of the brainstem, just above medulla oblongata. It connects upper and lower parts of the brain. The pons helps relay messages from the cortex and the cerebellum. We found OT immunoreactive fibers in and around the pons (Fig. 11).

OTR distribution

In contrast to OT immunohistochemistry, OTR staining was mainly found in cell somas with very little observed in fibers. Even though OTR immunoreactivity was found in several areas (lateral reticular nucleus (LRt), lateral septal nucleus (LSD), bed nucleus stria terminalis (BSTL), anterior hypothalamus area (AH), medioventral periolivary nucleus (MVPO), trapetzoid body (tz)), the most distinct OTR expression was found in the hippocampus (Fig. 12), the pons (Fig. 13) and the substantia nigra (SNR) (Fig. 14). In the pyramidal tract (py) and in the pyramidal decussation (pyx), thick positive fibers were found (Fig. 14).

Fig. 12
figure12

Oxytocin receptor immunohistochemistry of the hippocampus. Oxytocin receptor expression was found in the CA1 and CA2 regions of the hippocampus (CA1, CA2) and in the dentate gyrus. a. The left panel demonstrates positive pyramidal neurons in CA1. b. The right panel shows neurons of the dentate gyrus, with oxytocin receptor expression in both the cell soma and the processes

Fig. 13
figure13

Oxytocin receptor immunohistochemistry in the pons. Neurons in the pons (Pn) expressed oxytocin receptor in the cell soma

Fig. 14
figure14

Oxytocin receptor immunohistochemistry in the Substantia nigra and pyramidal tract. a. Neurons of the substantia nigra (SNR) expressed oxytocin receptor. Insert: Higher magnification of a positive neuron. b. The pyramidal tract (py) contained thick oxytocin receptor immunoreactive fibers

Match and mismatch, OT and OTR

In some regions of the brain (Fig. 1c), both OT and OTR were expressed (match). The most complete overlaps were found in SO, Pn, tz, py and LRt. In addition, both the amygdala and the hypothalamus were regions where OT and OTR expressions were observed. Mismatch was primarily confined to the cerebral and cerebellar cortex (OT expression) and hippocampus (OTR expression).

Migraine related regions, CGRP and OT

Several regions in the brain are thought to be involved in migraine based on human imaging studies and known pain pathways [27] (Fig. 1a). In the present study, we compared these regions with the expression of OT and OTR, and found congruent distribution in cerebral cortex and cerebellum, pons, amygdala, hypothalamus and Sp5 region.

We also compared the OT and the OTR expression with findings provided in our earlier CGRP distribution study [25]. As expected, CGRP expression coincide with migraine related regions (Figs. 1a and b). Consequently, cerebral cortex, cerebellum, hypothalamus, pons and Sp5 were regions where CGRP and OT expressions matched (Figs. 1b and c). In addition, in the hippocampal area the OTR and CGRP and its receptor expression overlapped.

Discussion

Migraine occurs in 15% of the general population, but its pathophysiology is not well understood. Imaging results have pointed towards the hypothalamus as a tentative initiation region for the migraine attack [27] and the attacks are often linked to symptoms like stress, depression, diurnal rhythms and autonomic dysfunctions, all of which point towards involvement of the hypothalamus. OT is an important hypothalamic neuropeptide/neurohormone with widespread actions in the periphery and CNS. Recent studies indicate that OT may be involved in migraine and that its administration may relieve acute attacks [15, 23, 30, 31]. In the present study, we demonstrate that OT and OTR are present in a number of brain regions associated with migraine, thus strengthening our insight into possible involvement of OT in migraine attacks.

Historically, OT neurons have been divided into two types, magnocellular and parvocellular OT cells, which project to the posterior pituitary [32,33,34]. In addition to magno- and parvocellular OT systems, there may be more types of OT neurons which cannot be characterized just by their size [35]. OT is transported to the posterior pituitary gland and secreted into the circulation from the pituitary nerve terminals to regulate numerous peripheral tissues. OT secreted from the pituitary does not enter the brain in significant amounts [36] and a major component of migraine pathophysiology – the trigeminovascular system – is a likely target of circulating OT as it lacks a blood-brain barrier (BBB) [37].

A central role of OT is that both OT and vasopressin are released within the brain by centrally projecting parvocellular neurons (fibers) and also from the soma and dendrites of magnocellular neurons [9, 38, 39]. Synthesis of OT from its precursor “prooxytophysin”, and the secretion of OT are modulated by estrogen, however, the magnocellular OT neurons do not express any of the classical estrogen receptors.

The most fascinating feature of the OT neuron is the long-range axonal projections [40], amply demonstrated in the present work. It has been shown that magnocellular OT neurons project to more than 50 forebrain regions, in addition to their well-known terminations in the posterior pituitary. Parvocellular OT projections give rise to central projections to the SO to influence magnocellular OT activity and simultaneously innervate the dorsal spinal cord to attenuate acute pain perception [41]. In the present study, we demonstrate using immunohistochemistry a delicate network of fibers expressing OT in many areas of the rat brain, however, the positive fibers in the cerebral cortex showed the most remarkably stunning organization, resembling the distribution of CGRP receptors [25].

Whereas neurotransmitters are ‘private’ messages from one neuron to another, neuropeptides, like OT, are messages between populations of cells — messages that can act across substantial distances linking widely dispersed cell groups, but which lack temporal accuracy or much spatial refinement [9]. To produce its actions in the brain, OT must reach and activate its main target, the OTR. This means that it is not the distribution of OT fibers in the brain that determines behavior, but the distribution of OTR [9]. When comparing migraine active regions seen in imaging studies of migraine patients [27] and the localization of OT/OTR, it shows that there is overlap in several parts of the brain.

In a recent review, the literature on the overlap OT/OTR in the rat brain has been summarized using autoradiography, in situ hybridization and immunohistochemistry [40]. The authors concluded that there is a complete overlap between OT fibers and OTR, but a mismatch appears in a few areas in the brain. Mismatch in the present study using immunohistochemistry was primarily confined to the cortex (OT expression) and hippocampus (OTR expression). The reason for this is unclear but, in many parts, the OT fibers distribute to the ependymal cells of the ventricles, suggestive of cerebral spinal fluid secretion, and to intracerebral microvessels, sometimes fibers reaching through the endothelium and hence suggestive of a secretion to the circulation [10].

Recent experiments have demonstrated that OTR are expressed in trigeminal ganglion neurons; some of which co-express CGRP, which is indicative of their presence on primarily nociceptive trigeminal neurons (Warfvinge, unpublished). Furthermore, OTR are up-regulated 1n trigeminal neurons following inflammatory and/or noxious stimulation.

Effects of OT on the trigeminal pathway have recently been elucidated by [42, 43]. Thus, the acute dura mater stimulation elicits neuronal activation in the trigeminocervical complex (TCC) in the brainstem [44]. This response in the TCC is blunted by spinal (local) OT administration [43]. In addition, the application of a OTR blocker reduced this response, indicating involvement of an OTR at the TCC level. Since the TNC/TCC is protected by the BBB it is reasonable that OT should come from a CNS site like the long slender neuronal fibers from the SO/Pa. The neuroanatomy provided presently support the functional data [42, 43]. We have shown that there are OT positive fibers projecting from the hypothalamic neurons to different parts of the brainstem.

Conclusion

The current study examined the CNS distribution of OT and its receptor with a focus on migraine-related regions and areas expressing CGRP/receptors. In many regions, in particular regions harboring the “migraine generator” in the brainstem, we found correlation between the three types of mappings. We propose that a central role for OT will be a key to understanding more about migraine pathophysiology.

Availability of data and materials

The material (stained and not-stained) are kept in the freezers in our laboratory. The data are kept in our computers and also kept in the back-up systems available at our institute.

Abbreviations

ac:

anterior commissure

AH:

Anterior hypothalamic area

Arc:

Arcuate hypothalamic nucleus

BBB:

Blood-brain barrier

BST:

Bed nucleus stria terminalis

CA1:

Field CA1 of the hippocampus

CA3:

Field CA3 of the hippocampus

Cb:

Cerebellum

CGRP:

Calcitonin gene-related peptide

CLR:

Calcitonin receptor-like receptor

DG:

Dentate gyrus

ECu:

External cuneate nucleus

ICj:

Islands of Calleja

LSD:

Lateral septal nucleus

LRt:

Lateral reticular nucleus

Me5:

Mesencephalic trigeminal nucleus

Med:

Medial cerebellar nucleus

MVPO:

Medioventral periolivary nucleus

och:

optic chiasm

Pa:

Paraventricular hypothalamic nucleus (also named PVN in the literature)

Pn:

Pons

py:

pyramidal tract

pyx:

pyramidal decussation

RAMP1:

Receptor activity-modifying protein 1

SNR:

Substantia nigra reticular part

SO:

Supraoptic nucleus (also named SON in the literature)

Sp5:

Spinal trigeminal nucleus

TCC:

Trigeminocervical complex

TNC:

Trigeminal nucleus caudalis

tz:

trapetzoid body

ZI:

Zona incerta

References

  1. 1.

    Murphy D, Si-Hoe SL, Brenner S et al (1998, 20) Something fishy in the rat brain: molecular genetics of the hypothalamo-neurohypophysial system. Bioessays:741–749 1998/11/20. DOI: https://doi.org/10.1002/(SICI)1521-1878(199809)20:9<741::AID-BIES7>3.0.CO;2-J

  2. 2.

    Vandesande F, Dierickx K (1975) Identification of the vasopressin producing and of the oxytocin producing neurons in the hypothalamic magnocellular neurosecretroy system of the rat. Cell Tissue Res 164:153–162 1975/12/02

  3. 3.

    Jirikowski GF, Caldwell JD, Pilgrim C et al (1989) Changes in immunostaining for oxytocin in the forebrain of the female rat during late pregnancy, parturition and early lactation. Cell Tissue Res 256:411–417. https://doi.org/10.1007/bf00218899

  4. 4.

    Buijs RM (1978) Intra- and extrahypothalamic vasopressin and oxytocin pathways in the rat. Pathways to the limbic system, medulla oblongata and spinal cord. Cell Tissue Res 192:423–435. 1978/09/26. https://doi.org/10.1007/bf00212323

  5. 5.

    Tribollet E, Charpak S, Schmidt A et al (1989) Appearance and transient expression of oxytocin receptors in fetal, infant, and peripubertal rat brain studied by autoradiography and electrophysiology. J Neurosci 9:1764–1773 1989/05/01

  6. 6.

    Gould BR, Zingg HH (2003) Mapping oxytocin receptor gene expression in the mouse brain and mammary gland using an oxytocin receptor-LacZ reporter mouse. Neuroscience 122:155–167. 2003/11/05. https://doi.org/10.1016/s0306-4522(03)00283-5

  7. 7.

    Boccia ML, Petrusz P, Suzuki K et al (2013) Immunohistochemical localization of oxytocin receptors in human brain. Neuroscience 253:155–164. 2013/09/10. https://doi.org/10.1016/j.neuroscience.2013.08.048

  8. 8.

    Marlin BJ, Froemke RC (2017) Oxytocin modulation of neural circuits for social behavior. Dev Neurobiol 77:169–189. 2016/09/15. https://doi.org/10.1002/dneu.22452

  9. 9.

    Ludwig M, Leng G (2006) Dendritic peptide release and peptide-dependent behaviours. Nat Rev Neurosci 7:126–136. 2006/01/24. https://doi.org/10.1038/nrn1845

  10. 10.

    Jirikowski GF (2019) Diversity of central oxytocinergic projections. Cell Tissue Res 375:41–48. 2018/12/01. https://doi.org/10.1007/s00441-018-2960-5

  11. 11.

    Ludwig M (1998) Dendritic release of vasopressin and oxytocin. J Neuroendocrinol 10:881–895 1998/12/31

  12. 12.

    Cilz NI, Cymerblit-Sabba A, Young WS (2019) Oxytocin and vasopressin in the rodent hippocampus. Genes Brain Behav 18:e12535. 2018/11/01. https://doi.org/10.1111/gbb.12535

  13. 13.

    Dumais KM, Veenema AH (2016) Vasopressin and oxytocin receptor systems in the brain: Sex differences and sex-specific regulation of social behavior. Front Neuroendocrinol 40:1–23. 2015/05/09. https://doi.org/10.1016/j.yfrne.2015.04.003

  14. 14.

    Gimpl G, Fahrenholz F (2001) The oxytocin receptor system: structure, function, and regulation. Physiol Rev 81:629–683. 2001/03/29. https://doi.org/10.1152/physrev.2001.81.2.629

  15. 15.

    Tzabazis A, Mechanic J, Miller J et al (2016) Oxytocin receptor: Expression in the trigeminal nociceptive system and potential role in the treatment of headache disorders. Cephalalgia 36:943–950. 2015/11/23. https://doi.org/10.1177/0333102415618615

  16. 16.

    Horta M, Kaylor K, Feifel D et al (2019) Chronic oxytocin administration as a tool for investigation and treatment: A cross-disciplinary systematic review. Neurosci Biobehav Rev 108:1–23. 2019/10/28. https://doi.org/10.1016/j.neubiorev.2019.10.012

  17. 17.

    Macdonald K, Feifel D (2013) Helping oxytocin deliver: considerations in the development of oxytocin-based therapeutics for brain disorders. Front Neurosci 7:35. 2013/03/20. https://doi.org/10.3389/fnins.2013.00035

  18. 18.

    Rash JA, Aguirre-Camacho A, Campbell TS (2014) Oxytocin and pain: a systematic review and synthesis of findings. Clin J Pain 30:453–462. 2013/07/28. https://doi.org/10.1097/AJP.0b013e31829f57df

  19. 19.

    Disease GBD, Injury I and Prevalence C (2017) Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390:1211–1259 2017/09/19. https://doi.org/10.1016/S0140-6736(17)32154-2

  20. 20.

    Paxinos G, Watson C (2007) The rat brain in stereotaxic coordinates, 6th edn. Academic Press, London

  21. 21.

    May A, Schulte LH (2016) Chronic migraine: risk factors, mechanisms and treatment. Nat Rev Neurol 12:455–464. 2016/07/09. https://doi.org/10.1038/nrneurol.2016.93

  22. 22.

    Edvinsson L, Uddman R (2005) Neurobiology in primary headaches. Brain Res Brain Res Rev 48:438–456. 2005/05/26. https://doi.org/10.1016/j.brainresrev.2004.09.007

  23. 23.

    Tzabazis A, Kori S, Mechanic J et al (2017) Oxytocin and Migraine Headache. Headache 57(Suppl 2):64–75. 2017/05/10. https://doi.org/10.1111/head.13082

  24. 24.

    Sundstrom Poromaa I, Comasco E, Georgakis MK et al (2017) Sex differences in depression during pregnancy and the postpartum period. J Neurosci Res 95:719–730. 2016/11/22. https://doi.org/10.1002/jnr.23859

  25. 25.

    Warfvinge K, Edvinsson L (2019) Distribution of CGRP and CGRP receptor components in the rat brain. Cephalalgia 39:342–353. 2017/09/01. https://doi.org/10.1177/0333102417728873

  26. 26.

    Warfvinge K, Edvinsson L (2013) Pearls and pitfalls in neural CGRP immunohistochemistry. Cephalalgia 33:593–603. 2013/05/15. https://doi.org/10.1177/0333102412472072

  27. 27.

    May A (2017) Understanding migraine as a cycling brain syndrome: reviewing the evidence from functional imaging. Neurol Sci 38:125–130. 2017/05/21. https://doi.org/10.1007/s10072-017-2866-0

  28. 28.

    Abrahams VC, Pickford M (1956) The effect of anticholinesterases injected into the supraoptic nuclei of chloralosed dogs on the release of the oxytocic factor of the posterior pituitary. J Physiol 133:330–333. 1956/08/28. https://doi.org/10.1113/jphysiol.1956.sp005589

  29. 29.

    Bouret SG, Draper SJ, Simerly RB (2004) Trophic action of leptin on hypothalamic neurons that regulate feeding. Science 304:108–110. 2004/04/06. https://doi.org/10.1126/science.1095004

  30. 30.

    Wang YL, Yuan Y, Yang J et al (2013) The interaction between the oxytocin and pain modulation in headache patients. Neuropeptides 47:93–97. 2013/02/05. https://doi.org/10.1016/j.npep.2012.12.003

  31. 31.

    You DS, Haney R, Albu S et al (2018) Generalized Pain Sensitization and Endogenous Oxytocin in Individuals With Symptoms of Migraine: A Cross-Sectional Study. Headache 58:62–77. 2017/11/03. https://doi.org/10.1111/head.13213

  32. 32.

    Swanson LW, Kuypers HG (1980) The paraventricular nucleus of the hypothalamus: cytoarchitectonic subdivisions and organization of projections to the pituitary, dorsal vagal complex, and spinal cord as demonstrated by retrograde fluorescence double-labeling methods. J Comp Neurol 194:555–570. 1980/12/01. https://doi.org/10.1002/cne.901940306

  33. 33.

    Swanson LW, Sawchenko PE (1980) Paraventricular nucleus: a site for the integration of neuroendocrine and autonomic mechanisms. Neuroendocrinology 31:410–417. 1980/12/01. https://doi.org/10.1159/000123111

  34. 34.

    Swanson LW, Sawchenko PE (1983) Hypothalamic integration: organization of the paraventricular and supraoptic nuclei. Annu Rev Neurosci 6:269–324. 1983/01/01. https://doi.org/10.1146/annurev.ne.06.030183.001413

  35. 35.

    Althammer F, Grinevich V (2017) Diversity of oxytocin neurons: beyond magno- and parvocellular cell types?, 2017/10/13. J Neuroendocrinol, DOI. https://doi.org/10.1111/jne.12549

  36. 36.

    Ermisch A, Brust P, Kretzschmar R et al (1993) Peptides and blood-brain barrier transport. Physiol Rev 73:489–527. 1993/07/01. https://doi.org/10.1152/physrev.1993.73.3.489

  37. 37.

    Edvinsson L, Haanes KA, Warfvinge K et al (2018) CGRP as the target of new migraine therapies - successful translation from bench to clinic. Nat Rev Neurol 14:338–350. 2018/04/25. https://doi.org/10.1038/s41582-018-0003-1

  38. 38.

    Pow DV, Morris JF (1989) Dendrites of hypothalamic magnocellular neurons release neurohypophysial peptides by exocytosis. Neuroscience 32:435–439 1989/01/01

  39. 39.

    Landgraf R, Neumann ID (2004) Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication. Front Neuroendocrinol 25:150–176. 2004/12/14. https://doi.org/10.1016/j.yfrne.2004.05.001

  40. 40.

    Grinevich V, Knobloch-Bollmann HS, Eliava M et al (2016) Assembling the Puzzle: Pathways of Oxytocin Signaling in the Brain. Biol Psychiatry 79:155–164. 2015/05/24. https://doi.org/10.1016/j.biopsych.2015.04.013

  41. 41.

    Eliava M, Melchior M, Knobloch-Bollmann HS et al (2016) A New Population of Parvocellular Oxytocin Neurons Controlling Magnocellular Neuron Activity and Inflammatory Pain Processing. Neuron 89:1291–1304. 2016/03/08. https://doi.org/10.1016/j.neuron.2016.01.041

  42. 42.

    Garcia-Boll E, Martinez-Lorenzana G, Condes-Lara M et al (2018) Oxytocin inhibits the rat medullary dorsal horn Sp5c/C1 nociceptive transmission through OT but not V1A receptors. Neuropharmacology 129:109–117. 2017/11/25. https://doi.org/10.1016/j.neuropharm.2017.11.031

  43. 43.

    Garcia-Boll E, Martinez-Lorenzana G, Condes-Lara M et al (2020) Inhibition of nociceptive dural input to the trigeminocervical complex through oxytocinergic transmission. Exp Neurol 323:113079. 2019/11/05. https://doi.org/10.1016/j.expneurol.2019.113079

  44. 44.

    Akerman S, Holland PR, Lasalandra MP et al (2013) Endocannabinoids in the brainstem modulate dural trigeminovascular nociceptive traffic via CB1 and “triptan” receptors: implications in migraine. J Neurosci 33:14869–14877. 2013/09/13. https://doi.org/10.1523/JNEUROSCI.0943-13.2013

Download references

Acknowledgements

The Lundbeck Foundation, Denmark, the Swedish Research Council, the Heart-Lung foundation, Sweden, and the International Headache Society generously supported this work.

Authors’ information (optional)

LE was the first to propose that CGRP might be involved in migraine. LE has over the years investigated different angles when it comes to migraine and CGRP. In 2018, the first migraine specific drug (Aimovig®), an antibody against the CGRP receptor, was approved by US FDA and EU EMA. DK expertise in male and female hormones is a result from 30 odd year’s investigation on hormonal effects. KW is an expert in immunohistochemical methods and CNS.

Funding

The Lundbeck Foundation, Denmark, the Swedish Research Council, the Heart-Lung foundation, Sweden, and the International Headache Society are gratefully acknowledged. Open access funding provided by Lund University.

Author information

KW, DK and LE formed the plan of the project. KW did all the immunohistochemical staining and images. KW, DK and LE analyzed the results. KW, DK and LE wrote the manuscript. KW, DK and LE approved to the final manuscript.

Correspondence to Karin Warfvinge.

Ethics declarations

Ethics approval and consent to participate

The study followed the guidelines of the European Communities Council (86/609/ECC) and was approved by the Regional Ethical Committee on Animal Research, Malmö/Lund, Sweden (M17–15).

Consent for publication

All authors approved the publication of this paper.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Warfvinge, K., Krause, D. & Edvinsson, L. The distribution of oxytocin and the oxytocin receptor in rat brain: relation to regions active in migraine. J Headache Pain 21, 10 (2020). https://doi.org/10.1186/s10194-020-1079-8

Download citation

Keywords

  • Immunohistochemistry
  • Oxytocin
  • Oxytocin receptor
  • Migraine-related regions
  • CGRP, CGRP receptors